Product Image

Glucosamine + Chondroitin + MSM

Jarrow Formulas
4.7
★ ★ ★ ★ ★
(7263 ratings)
Sodium 120 mg
Potassium 260 mg
Product Image
Score83
A substantial glucosamine-chondroitin formula with MSM and supporting nutrients. It is well suited to joint use, but not heart support, and anticoagulant users need specific caution.
How scoring works
Quantity:240 Capsule(s) • (60 servings)
Goals:

Score 83

A substantial glucosamine-chondroitin formula with MSM and supporting nutrients. It is well suited to joint use, but not heart support, and anticoagulant users need specific caution.
How scoring works
$37.65($0.62 per serving)
Vitacost
$ 48.47
Pure Formulas
$ 40.99
Vitacost
$ 50.47
Daily Vita
$ 42.99
Amazon
$ 37.65
iHerb
$ 50.47
Report prices

Analysis

The four-capsule serving supplies 1,500 mg glucosamine sulfate, 1,200 mg chondroitin sulfate, and 300 mg MSM. Vitamin C and manganese add modest connective-tissue support.

Potassium contributes 260 mg and sodium 120 mg, but those amounts are incidental to the joint ingredients. They do not turn the formula into a strong heart-health or hydration product.

The generous capsule supply supports regular joint-focused use, although four capsules may be inconvenient. Chondroitin is the key safety consideration for people taking medicines that affect clotting.

Who is it for
  • Adults seeking broad joint-support ingredients
  • People comfortable with four capsules per serving
  • Users who value substantial glucosamine and chondroitin amounts
Best for
  • Joint-focused supplementation
  • Combining glucosamine, chondroitin, and MSM
  • Longer-term capsule use

Pros

  • Provides substantial glucosamine and chondroitin amounts
  • Adds MSM, vitamin C, and manganese
  • Clearly discloses the main active quantities

Cons

  • Requires four capsules per serving
  • Potassium amount is modest
  • Poor fit when heart health is the main goal

Warnings

  • Chondroitin may raise bleeding risk with warfarin or other anticoagulants; use that combination only with medication-specific clinical guidance.

Nutrient quality

89 Highest impact

Meaningful glucosamine and chondroitin doses anchor a coherent joint formula. A modest MSM amount is the main limitation.

.

Ingredient transparency

84 Highest impact

Active amounts are clear and no proprietary blend obscures the core formula. Non-active ingredients and full usage directions remain undisclosed.

.

Customer satisfaction

70 High impact

The supplied average rating is strong. No specific review comments were supplied, so repeated negative experiences cannot be assessed.

.

Value for money

85 Highest impact

The core joint ingredients provide good value per serving. Underdosed MSM is a modest weakness rather than a major cost burden.

.
Report analysis

Ingredients

IngredientAmount per serving
Vitamin C (Ascorbic Acid)
60 mg
Manganese (Manganese Citrate)
1 mg
Sodium (Chondroitin Sulfate Sodium)
120 mg
Potassium (Glucosamine Sulfate Potassium Chloride)
260 mg
Glucosamine Sulfate
1500 mg
Chondroitin Sulfate
1200 mg
Methylsulfonylmethane
300 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
D+ Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyA+ Value

The sodium amount is too low for exercise replenishment and is incidental to chondroitin delivery. Potassium chloride provides a standard co-electrolyte, but magnesium and buffering compounds are absent. The economical serving cost favors joint-support use rather than athletic hydration.

D+ Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyC Value

The formula supplies a moderate potassium amount as part of a multi-ingredient joint supplement. Its chloride source is practical for electrolyte replacement but offers less metabolic versatility than citrate or bicarbonate. Fair serving efficiency depends on valuing the glucosamine, chondroitin, and MSM as well as the potassium.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  2. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  3. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.
    Seth A; Mossavar-Rahmani Y; Kamensky V; Silver B; Lakshminarayan K; Prentice R; Van Horn L; Wassertheil-Smoller S · Stroke · 2015
    Cohort study90,137 participantsHeart Health forPotassium
  4. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  5. Associations between sodium, potassium, and blood pressure: results from the Hispanic Community Health Study/Study of Latinos, a prospective cohort study.
    Swift SL; Sotres-Alvarez D; Raij L; Wassertheil-Smoller S; Schneiderman N; Llabre M; Zeki Al Hazzouri A; Rundek T; Van Horn L; Daviglus M; Castaneda S; Youngblood M; Mossavar-Rahmani Y; Elfassy T · The American journal of clinical nutrition · 2024
    Cohort study11,429 participantsHeart Health forPotassium
  6. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR · ESC heart failure · 2021
    Cohort study178 participantsHeart Health forPotassium
  7. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J · Circulation · 2019
    Cohort study2,164 participantsHeart Health forPotassium
  8. Effect of high potassium diet on endothelial function.
    Blanch N; Clifton PM; Petersen KS; Willoughby SR; Keogh JB · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2015
    Randomized trial35 participantsHeart Health forPotassium